CELGENE LIMITED
Get an alert when CELGENE LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-05-20 (this month)
Last made up 2025-05-06
Watchouts
Cash
—
Latest balance sheet
Net assets
£2
0% vs 2023
Employees
0
Average over period
Profit before tax
—
Period ending 2024-12-31
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
The directors have prepared the financial statements on a basis other than going concern. Further details can be found in note 2.3 to the financial statements.
Name history
Renamed 1 time since incorporation
- CELGENE LIMITED 2006-05-18 → present
- CELGENE UK MARKETING LIMITED 2005-06-02 → 2006-05-18
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | -£992,256 | -£992,256 | |
| Profit before tax | £3,464,807 | — | |
| Net profit | £2,433,760 | £0 | |
| Cash | — | — | |
| Total assets less current liabilities | — | — | |
| Net assets | £2 | £2 | |
| Equity | £2 | £2 | |
| Average employees | 0 | 0 | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Current ratio | 1.00x | 1.00x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Audit opinion
- Unaudited (audit-exempt)
- Going concern
- Material uncertainty disclosed
“The directors have prepared the financial statements on a basis other than going concern. Further details can be found in note 2.3 to the financial statements.”
Significant events
- “From 1 October 2022, the company was a non-trading entity. The company's trade, assets and liabilities were transferred on 1 October 2022 to Bristol-Myers Squibb Pharmaceuticals Limited. The directors plan to liquidate the company during the financial year of 2026.”
- “There have been no significant events since the year end that require adjustment to or disclosure in the financial statements.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
1 active · 29 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ONG, Annie | Director | 2023-11-08 | Apr 1974 | Malaysian |
Show 29 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CITCO MANAGEMENT (UK) LIMITED | Corporate Secretary | 2011-02-03 | 2025-06-15 |
| COMAT CONSULTING SERVICES LIMITED | Corporate Secretary | 2005-06-02 | 2011-02-02 |
| ALLMOND, David James | Director | 2006-10-20 | 2008-10-01 |
| BAZARKO, Daniel Adrian | Director | 2012-02-20 | 2013-06-07 |
| BILLER, Jonathan Prim | Director | 2012-02-20 | 2019-02-20 |
| BROUWER, Aart | Director | 2006-10-20 | 2011-05-16 |
| COLOWICK, Alan Burton | Director | 2012-02-20 | 2014-09-15 |
| COOKE, John Scott | Director | 2021-07-20 | 2023-11-08 |
| FLANIGAN III, Patrick Eugene | Director | 2019-02-20 | 2019-11-26 |
| GUJER, Remo | Director | 2017-01-01 | 2019-11-26 |
| HOCH, Lynelle B. | Director | 2019-11-26 | 2021-07-20 |
| HUGIN, Robert | Director | 2005-06-02 | 2006-10-20 |
| JABLONSKI, Kimberly Mccutcheon | Director | 2022-01-19 | 2026-01-28 |
| JASKO, Stephen | Director | 2005-06-02 | 2008-09-05 |
| KELLY, Katherine Reynolds | Director | 2019-11-26 | 2021-09-17 |
| MAHATME, Sandesh | Director | 2006-10-20 | 2012-02-20 |
| MORRISSEY, Michael | Director | 2005-06-02 | 2006-10-20 |
| OEHEN, Jurg | Director | 2006-10-20 | 2019-02-20 |
| PATSI, Tuomo Tapani | Director | 2014-09-15 | 2020-04-30 |
| PATSI, Tuomo Tapani | Director | 2009-06-30 | 2010-07-16 |
| PEARCE, Samantha Jane Laura | Director | 2011-05-16 | 2014-11-17 |
| PIGNOLET, David Walter | Director | 2019-02-20 | 2022-01-19 |
| ROBERTSON, Andrew Howard | Director | 2008-10-01 | 2009-06-30 |
| SERRY, Nakisa | Director | 2013-06-07 | 2020-04-30 |
| SOUVERIJNS, Wim Jozef Maria Guido | Director | 2014-11-17 | 2016-11-21 |
| VAN HOEK, Andre Laurent Elisabeth Maria | Director | 2008-09-05 | 2012-02-20 |
| VAN HOLLE, Phiippe Marie Marcel Joseph | Director | 2006-10-20 | 2012-02-20 |
| VARGAS QUINTAS CAMPOS, Teresa Maria | Director | 2020-04-30 | 2022-10-03 |
| WATTERS, Kenneth John, Dr | Director | 2005-06-02 | 2006-10-20 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Bristol-Myers Squibb Pharmaceuticals Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2022-07-31 | Active |
| Celgene Uk Manufacturing (Ii) Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2022-07-31 |
Filing timeline
Last 20 of 159 total filings
Material constitutional events — rename, articles re-file, resolution
- 2023-09-29 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-01-30 | TM01 | officers | Termination director company with name termination date | |
| 2026-01-20 | AA | accounts | Accounts with accounts type full | |
| 2025-06-30 | AD02 | address | Change sail address company with old address new address | |
| 2025-06-30 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-05-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-10-10 | AA | accounts | Accounts with accounts type full | |
| 2024-05-21 | RP04CS01 | confirmation-statement | Second filing of confirmation statement with made up date | |
| 2024-05-15 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-11-17 | TM01 | officers | Termination director company with name termination date | |
| 2023-11-17 | AP01 | officers | Appoint person director company with name date | |
| 2023-09-29 | SH19 | capital | Capital statement capital company with date currency figure | |
| 2023-09-29 | SH20 | capital | Legacy | |
| 2023-09-29 | CAP-SS | insolvency | Legacy | |
| 2023-09-29 | RESOLUTIONS | resolution | Resolution | |
| 2023-08-07 | AA | accounts | Accounts with accounts type full | |
| 2023-07-24 | CH01 | officers | Change person director company with change date | |
| 2023-05-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-10-03 | TM01 | officers | Termination director company with name termination date | |
| 2022-09-29 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2022-09-23 | AD01 | address | Change registered office address company with date old address new address |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
—
Not reported
-
Net assets
0%
£2 £2
-
Employees
—
Not reported
-
Operating profit
0%
-£992,256 -£992,256
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers